Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization

被引:33
作者
Delpón, E [1 ]
Caballero, R [1 ]
Gómez, R [1 ]
Núñez, L [1 ]
Tamargo, J [1 ]
机构
[1] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain
关键词
D O I
10.1016/j.tips.2005.01.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Angiotensin II and aldosterone produce pro-arrhythmic effects by several mechanisms, including the modulation of voltage-dependent K+ channels involved in human cardiac repolarization. Drugs that inhibit the renin-angiotensin-aidosterone system exert antiarrhythmic actions that are related to the blockade of the pro-arrhythmic actions of angiotensin II and aldosterone. These anti-arrhythmic actions include inhibition of electrical and structural cardiac remodeling, inhibition of neurohumoral activation, reduction of blood pressure and stabilization of electrolyte disturbances. In this article, several angiotensin II AT(1) receptor antagonists (candesartan, E3174, eprosartan, irbesartan and losartan) and aldosterone receptor antagonists (canrenoic acid and spironolactone) that directly modulate the activity of the voltage-dependent K+ channels are reviewed; the effects of these antagonists might be useful in the prevention and treatment of cardiac arrhythmias.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 68 条
[1]   Angiotensin II stimulates cardiac L-type Ca2+ current by a Ca2+- and protein kinase C-dependent mechanism [J].
Aiello, EA ;
Cingolani, HE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (04) :H1528-H1536
[2]   Differences in tissue angiotensin II-forming pathways by species and organs in vitro [J].
Akasu, M ;
Urata, H ;
Kinoshita, A ;
Sasaguri, M ;
Ideishi, M ;
Arakawa, K .
HYPERTENSION, 1998, 32 (03) :514-520
[3]   Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes [J].
Bénitah, JP ;
Perrier, E ;
Gómez, AM ;
Vassort, G .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 537 (01) :151-160
[4]   Expression of voltage-gated K+ channels in human atrium [J].
Bertaso, F ;
Sharpe, CC ;
Hendry, BM ;
James, AF .
BASIC RESEARCH IN CARDIOLOGY, 2002, 97 (06) :424-433
[5]   Early class III drugs for the treatment of atrial fibrillation -: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat [J].
Blaauw, Y ;
Gögelein, H ;
Tieleman, RG ;
van Hunnik, A ;
Schotten, U ;
Allessie, MA .
CIRCULATION, 2004, 110 (13) :1717-1724
[6]   ANTIFIBRILLATORY EFFECTS OF ELECTROLYTE-REGULATING STEROIDS ON ISOLATED RABBIT ATRIA [J].
BRIGGS, AH ;
HOLLAND, WC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1959, 197 (06) :1161-1164
[7]   Angiotensin-converting enzyme inhibitors [J].
Brown, NJ ;
Vaughan, DE .
CIRCULATION, 1998, 97 (14) :1411-1420
[8]   Angiotensin II type 1 receptor blockers [J].
Burnier, M .
CIRCULATION, 2001, 103 (06) :904-912
[9]  
Caballero R, 2004, EUR HEART J, V25, P629
[10]   Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current [J].
Caballero, R ;
Gómez, R ;
Moreno, I ;
Núñez, L ;
González, T ;
Arias, C ;
Guizy, M ;
Valenzuela, C ;
Tamargo, J ;
Delpón, E .
CARDIOVASCULAR RESEARCH, 2004, 62 (01) :86-95